NCT02784795 A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT02784171 Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE2/PHASE3
NCT02784015 Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma Status UNKNOWN Phase PHASE2
NCT02778191 Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase N/A
NCT02777385 Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT02775812 Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT02768558 Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC Status TERMINATED Phase PHASE3
NCT02764593 Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02760901 Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity Status COMPLETED Phase PHASE2
NCT02759575 A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02754726 Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02753140 Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE2
NCT02750670 Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT02749526 Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial Status TERMINATED Phase PHASE2
NCT02743923 Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT02741856 Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation Status UNKNOWN Phase PHASE2/PHASE3
NCT02741388 A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP Status COMPLETED Phase PHASE1
NCT02734537 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery Status RECRUITING Phase PHASE2